Viatris (VTRS) Exchange Rate Effect (2019 - 2026)
Viatris (VTRS) posted Exchange Rate Effect of -$3.3 million for Q2 2026, up 21.43% on a QoQ basis from -$4.2 million in Q1 2026, and down 149.25% year-over-year from $6.7 million in Q2 2025.
Analysis
Viatris (VTRS) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Viatris has reported Exchange Rate Effect for 8 years, with the latest figure at -$3.3 million in Q2 2026.
- On a quarterly basis, Exchange Rate Effect fell 149.25% year-over-year to -$3.3 million in Q2 2026; TTM through Jun 2026 was -$13.4 million, a 239.58% decrease from a year earlier, with the FY2025 full-year figure at $17.6 million, up 157.33% from the prior year.
- Exchange Rate Effect was -$3.3 million for Q2 2026 at Viatris, up from -$4.2 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $23.9 million in Q3 2024, with the low at -$37.8 million in Q4 2024.
- Average Exchange Rate Effect over 5 years is -$3.4 million, with a median of -$3.8 million recorded in 2026.
- The largest YoY upside for Exchange Rate Effect was 1139.13% in 2024 against a maximum downside of 1133.33% in 2024.
- Over 5 years, Exchange Rate Effect stood at $15.6 million in 2022, then decreased by 18.59% to $12.7 million in 2023, then sank by 397.64% to -$37.8 million in 2024, then soared by 37.3% to -$23.7 million in 2025, then jumped by 86.08% to -$3.3 million in 2026.
- The last three Exchange Rate Effect figures came in at -$3.3 million (Q2 2026), -$4.2 million (Q1 2026), and -$23.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | -5.00 Mn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | -3.30 Mn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 411,947.57 |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | -164,000.00 |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | -2.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -2.13 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 67,000.00 |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 16,000.00 |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.30 Mn |
| Mar 31, 2026 | -4.20 Mn |
| Dec 31, 2025 | -23.70 Mn |
| Sep 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Mar 31, 2025 | 16.80 Mn |
| Dec 31, 2024 | -37.80 Mn |
| Sep 30, 2024 | 23.90 Mn |
| Jun 30, 2024 | -4.40 Mn |
| Mar 31, 2024 | -12.40 Mn |
| Dec 31, 2023 | 12.70 Mn |
| Sep 30, 2023 | -2.30 Mn |
| Jun 30, 2023 | -14.10 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 15.60 Mn |
| Sep 30, 2022 | -14.30 Mn |
| Jun 30, 2022 | -28.80 Mn |
| Mar 31, 2022 | -11.40 Mn |
| Dec 31, 2021 | -10.30 Mn |
| Sep 30, 2021 | -7.30 Mn |